{"entity":{"type":"insider","cik":"0001688269","url":"/insider/0001688269","json_url":"/insider/0001688269.json","name":"Lettmann Jason","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":10,"first":"2016-10-31","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Lettmann Jason","source":"filing","n_filings":10,"first_seen":"2016-10-31","last_seen":"2026-08-18"}],"transactions":[{"id":9255890,"accession":"0001193125-26-355764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-355764","line_url":"/filing/0001193125-26-355764#line-1","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2230.0,"shares_display":"2,230","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":4303.9,"total_display":"4,303.90","total_whole":"4,304","shares_owned_after":294379.0,"shares_owned_after_display":"294,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":5784963,"accession":"0001193125-26-119705","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-119705","line_url":"/filing/0001193125-26-119705#line-1","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12311.0,"shares_display":"12,311","price_per_share":2.17,"price_display":"2.17","price_state":"stated","total_value":26714.87,"total_display":"26,714.87","total_whole":"26,715","shares_owned_after":293609.0,"shares_owned_after_display":"293,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-23","scope":"insider"},{"id":4845163,"accession":"0001193125-25-207432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-207432","line_url":"/filing/0001193125-25-207432#line-2","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71163.0,"shares_display":"71,163","price_per_share":1.0805,"price_display":"1.08","price_state":"stated","total_value":76891.6215,"total_display":"76,891.62","total_whole":"76,892","shares_owned_after":305121.0,"shares_owned_after_display":"305,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-18","scope":"insider"},{"id":4845159,"accession":"0001193125-25-207432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-207432","line_url":"/filing/0001193125-25-207432#line-1","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21070.0,"shares_display":"21,070","price_per_share":1.066,"price_display":"1.07","price_state":"stated","total_value":22460.62,"total_display":"22,460.62","total_whole":"22,461","shares_owned_after":233958.0,"shares_owned_after_display":"233,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":4419285,"accession":"0000950170-25-110099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-110099","line_url":"/filing/0000950170-25-110099#line-1","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2382.0,"shares_display":"2,382","price_per_share":0.6404,"price_display":"0.64","price_state":"stated","total_value":1525.4328,"total_display":"1,525.43","total_whole":"1,525","shares_owned_after":212888.0,"shares_owned_after_display":"212,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-19","scope":"insider"},{"id":4640194,"accession":"0001415889-25-005067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-005067","line_url":"/filing/0001415889-25-005067#line-1","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2159.0,"shares_display":"2,159","price_per_share":1.1502,"price_display":"1.15","price_state":"stated","total_value":2483.2818,"total_display":"2,483.28","total_whole":"2,483","shares_owned_after":170270.0,"shares_owned_after_display":"170,270","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-21","scope":"insider"},{"id":2659807,"accession":"0001415889-24-008260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-008260","line_url":"/filing/0001415889-24-008260#line-1","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Officer (CHIEF EXECUTIVE OFFICER)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF EXECUTIVE OFFICER","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4400.0,"shares_display":"4,400","price_per_share":11.3117,"price_display":"11.31","price_state":"stated","total_value":49771.48,"total_display":"49,771.48","total_whole":"49,771","shares_owned_after":171620.0,"shares_owned_after_display":"171,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-18","scope":"insider"},{"id":4564746,"accession":"0000899243-21-048463","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-21-048463","line_url":"/filing/0000899243-21-048463","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325377.0,"shares_display":"325,377","price_per_share":27.358430220943706,"price_display":"27.36","price_state":"stated","total_value":8901803.95,"total_display":"8,901,803.95","total_whole":"8,901,804","shares_owned_after":2101291.0,"shares_owned_after_display":"2,101,291","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider","n_lines":12},{"id":5438058,"accession":"0001209191-21-069154","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-21-069154","line_url":"/filing/0001209191-21-069154","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26274.0,"shares_display":"26,274","price_per_share":31.313043312780696,"price_display":"31.31","price_state":"stated","total_value":822718.9,"total_display":"822,718.90","total_whole":"822,719","shares_owned_after":2140002.0,"shares_owned_after_display":"2,140,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-10","scope":"insider","n_lines":6},{"id":5438048,"accession":"0001209191-21-069154","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-069154","line_url":"/filing/0001209191-21-069154","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76905.0,"shares_display":"76,905","price_per_share":32.033049476627006,"price_display":"32.03","price_state":"stated","total_value":2463501.67,"total_display":"2,463,501.67","total_whole":"2,463,502","shares_owned_after":2177065.0,"shares_owned_after_display":"2,177,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-10","scope":"insider","n_lines":6},{"id":5438037,"accession":"0001209191-21-069154","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-069154","line_url":"/filing/0001209191-21-069154","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42458.0,"shares_display":"42,458","price_per_share":33.253346130293465,"price_display":"33.25","price_state":"stated","total_value":1411870.57,"total_display":"1,411,870.57","total_whole":"1,411,871","shares_owned_after":2232251.0,"shares_owned_after_display":"2,232,251","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-08","filed_date":"2021-12-10","scope":"insider","n_lines":4},{"id":2857783,"accession":"0000899243-20-019931","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-019931","line_url":"/filing/0000899243-20-019931","is_derivative":false,"issuer_cik":"0001688269","issuer_name":"ALX ONCOLOGY HOLDINGS INC","issuer_ticker":"ALXO","issuer_name_source":null,"issuer_url":"/issuer/0001688269","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":7600000.0,"total_display":"7,600,000.00","total_whole":"7,600,000","shares_owned_after":378000.0,"shares_owned_after_display":"378,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider","n_lines":2},{"id":2596104,"accession":"0001104659-16-153348","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001104659-16-153348","line_url":"/filing/0001104659-16-153348#line-11","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":340.0,"shares_display":"340","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":4420.0,"total_display":"4,420.00","total_whole":"4,420","shares_owned_after":79821.0,"shares_owned_after_display":"79,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider"},{"id":2596100,"accession":"0001104659-16-153348","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001104659-16-153348","line_url":"/filing/0001104659-16-153348","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688269","owner_name":"Lettmann Jason","owner_display_name":"Lettmann Jason","owner_url":"/insider/0001688269","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":393923.0,"shares_display":"393,923","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5120999.0,"total_display":"5,120,999.00","total_whole":"5,120,999","shares_owned_after":3936118.0,"shares_owned_after_display":"3,936,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-31","filed_date":"2016-10-31","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":33,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001810182","name":"ALX ONCOLOGY HOLDINGS INC","url":"/issuer/0001810182","role":"Director, Officer (CHIEF EXECUTIVE OFFICER), Ten percent owner","n_filings":9,"first_seen":"2020-07-21","last_seen":"2026-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Director","n_filings":1,"first_seen":"2016-10-31","last_seen":"2016-10-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001688269","retrieved_at":"2026-08-22T09:29:46+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}